| 发明名称 |
USE OF TOLL-LIKE RECEPTOR-9 AGONISTS, TOLL-LIKE RECEPTOR-4 ANTAGONISTS, AND/OR NUCLEAR OLIGOMERIZATION DOMAIN-2 AGONISTS FOR THE TREATMENT OR PREVENTION OF TOLL-LIKE RECEPTOR-4-ASSOCIATED DISORDERS |
| 摘要 |
The present invention relates to the use of a TLR9 agonist and/or a TLR4 antagonist and/or a NOD2 agonist for treatment or prevention of disorders involving TLR4 activation, such as systemic sepsis and necrotizing enterocolitis.
|
| 申请公布号 |
US2008311112(A1) |
申请公布日期 |
2008.12.18 |
| 申请号 |
US20080104816 |
申请日期 |
2008.04.17 |
| 申请人 |
HACKAM DAVID J;RICHARDSON WARD M;GRIBAR STEVEN C;DUCRUET ALEXANDER P |
发明人 |
HACKAM DAVID J.;RICHARDSON WARD M.;GRIBAR STEVEN C.;DUCRUET ALEXANDER P. |
| 分类号 |
A61K31/7084;A61K38/05;A61K38/12;A61K39/395;A61P31/04 |
主分类号 |
A61K31/7084 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
